Literature DB >> 15645072

[Aripiprazole and Tourette syndrome].

Ana Hounie, Alice De Mathis, Aline Santos Sampaio, Marcos Tomanik Mercadante.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15645072     DOI： 10.1590/s1516-44462004000300015

Source DB:  PubMed          Journal:  Braz J Psychiatry        ISSN： 1516-4446            Impact factor:   2.697


× No keyword cloud information.
  6 in total

1.  Treatment strategies for tics in Tourette syndrome.

Authors:  Clare M Eddy; Hugh E Rickards; Andrea E Cavanna
Journal:  Ther Adv Neurol Disord       Date:  2011-01       Impact factor: 6.570

2.  Aripiprazole for the treatment of Tourette's disorder.

Authors:  Prasad R Padala; S Faiz Qadri; Vishal Madaan
Journal:  Prim Care Companion J Clin Psychiatry       Date:  2005

3.  Aripiprazole in children and adolescents with Tourette's disorder: an open-label safety and tolerability study.

Authors:  Gholson J Lyon; Stephanie Samar; Rahil Jummani; Scott Hirsch; Arie Spirgel; Rachel Goldman; Barbara J Coffey
Journal:  J Child Adolesc Psychopharmacol       Date:  2009-12       Impact factor: 2.576

4.  European clinical guidelines for Tourette syndrome and other tic disorders. Part II: pharmacological treatment.

Authors:  Veit Roessner; Kerstin J Plessen; Aribert Rothenberger; Andrea G Ludolph; Renata Rizzo; Liselotte Skov; Gerd Strand; Jeremy S Stern; Cristiano Termine; Pieter J Hoekstra
Journal:  Eur Child Adolesc Psychiatry       Date:  2011-04       Impact factor: 4.785

5.  Update on the role of antipsychotics in the treatment of Tourette syndrome.

Authors:  Daniel Huys; Katja Hardenacke; Pia Poppe; Christina Bartsch; Burak Baskin; Jens Kuhn
Journal:  Neuropsychiatr Dis Treat       Date:  2012-03-12       Impact factor: 2.570

6.  Aripiprazole Improves Associated Comorbid Conditions in Addition to Tics in Adult Patients with Gilles de la Tourette Syndrome.

Authors:  Sarah Gerasch; Ahmad Seif Kanaan; Ewgeni Jakubovski; Kirsten R Müller-Vahl
Journal:  Front Neurosci       Date:  2016-09-12       Impact factor: 4.677
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.